Clinical Study
The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy
Table 4
Antigen staining in different cell compartments. The percentages represent cases showing any immunopositivity.
| | Target protein | Cytoplasmic staining, pretreatment (%) | Cytoplasmic staining, posttreatment (%) | Nuclear staining, pretreatment (%) | Nuclear staining, posttreatment (%) |
| | Keap1 | 100.0 | 100.0 | 45.3 | 88.9 | | Nrf2 | 94.6 | 100.0 | 0 | 0 | | Prx I | 100.0 | 100.0 | 45.9 | 100.0 | | Trx | 94.6 | 100.0 | 64.9 | 81.8 |
|
|